News
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Snipp Interactive Reports Q1 2026 Financial Results; Bookings Backlog Reaches Record $20.6 Million; Announces Conference Call on Wednesday, June 3, 2026
Snipp Interactive Inc. announces Q1 2026 financial results under IFRS, USD. Revenue down 21%, record bookings backlog $20.6M, EBITDA $(0.3)M. AI integration and cost discipline focus -
COMMUNIQUÉ DE PRESSE
DBV Technologies Announces First Participant Screened in THRIVE Phase 2 Study of the VIASKIN® Peanut Patch in Infants ages 6 through 12 Months with Peanut Allergy
DBV Technologies screens first participant in THRIVE Phase 2 study of VIASKIN Peanut Patch for infants with peanut allergy. Study aims to achieve ad lib consumption of dietary peanut in infants 6-12 months -
COMMUNIQUÉ DE PRESSE
DBV Technologies annonce le screening du premier participant de l’étude clinique de phase 2 THRIVE pour le patch VIASKIN® Peanut chez les nourrissons âgés de 6 à 12 mois allergiques à l’arachide
DBV Technologies a annoncé le screening du premier participant de l’étude clinique de phase 2 THRIVE pour le patch VIASKIN® Peanut chez les nourrissons allergiques à l’arachide -
-
COMMUNIQUÉ DE PRESSE
Onco-Innovations Advances 1kg Scale-Up of B4 Precursor Supporting ONC010 Manufacturing and Clinical Development Program
Onco-Innovations successfully scales kilogram manufacturing for ONC010 B4 precursor component, advancing nanoparticle-formulated PNKP Inhibitor Technology. Engages InvestorBrandNetwork (IBN) for market services
![Logo de [UNKNOWN]](https://logos.symex.be/img/.jpg)
